The second three months of 2015 brought a 30 percent increase in venture capital deals nationwide, with software companies seeing the biggest investment to the tune of $7.3 billion.
Maryland mirrored the first part of that trend, but continues to see biotech leading the pace in the industry space.
According to data released in the quarterly MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association, the second quarter of 2015 saw a $25 million increase in the amount of money invested in Maryland-based companies, with about $137 million put up by VCs.
The bulk of that money was in the biotech space, where $88 million was invested.
Specifically, it was in one $70 million deal landed by Rockville-based gene therapy company Regenxbio. Consumer products and services was the second-highest investment category, bolstered by a $16 million deal for Rockville-based restaurant operator C.A.V.A.
Software was down significantly after posting a $39 million first quarter, but a $3 million round for Baltimore-based 6th Street led the way.
Here are 5 Baltimore-area deals of note for the second quarter, with links to our prior stories:
- ETC-based 6th Street, makers of ecommerce platform SalesWarp, landed a $3 million investment.
- Merkle, a Columbia marketing company, raised $2 million.
- DreamIt Health Baltimore grad Avhana Health raised $750,000.
- Sonify Biosciences, which makes a melanoma treatment, raised $145,000 from the Abell Venture Fund.
- Lutherville-based CSA Medical, which makes a spray for cryotherapy treatment, raised $2.9 million.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
